Arbutus Biopharma Corporation
ABUS
|
$2.97
2.06%
2.68%
3.6M
|
Health Technology
(0.0% 1d) (16.9% 1m) (1.4% 1y) (0.0% 2d) (0.0% 3d) (-0.3% 7d) (444.29% volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 533,091,831
http://www.arbutusbio.com
Sec Filling | Patents | 80 employees
(US) Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.
hepatitis injection
add to watch list Paper trade email alert is off
Press-releases
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
Published: 2024-04-04 (Crawled : 12:30) - globenewswire.com
MRNA S | $103.86 -1.22% -1.23% 1.9M
|
Health Technology
|
| O: 1.46%
H: 3.2%
C: -0.41%
ABUS | $2.97 2.06% 2.68% 3.6M
|
Health Technology
|
| O: 16.73%
H: 6.14%
C: 2.39%
patent construction biopharma ongoing
Barinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments
Published: 2024-03-20 (Crawled : 12:00) - globenewswire.com
ABUS | $2.97 2.06% 2.68% 3.6M
|
Health Technology
|
| O: -1.58%
H: 3.05%
C: 2.41%
year update financial results
Lipid-Nanoparticle Based Genomic Medicines Market worth $32.5 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
Published: 2024-03-18 (Crawled : 14:00) - prnewswire.com
CVAC | $2.65 -8.94% -9.81% 930K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.73%
BNTX | $87.89 1.63% 1.59% 710K
|
Health Technology
|
| O: 0.48%
H: 1.18%
C: 0.08%
ABUS | $2.97 2.06% 2.68% 3.6M
|
Health Technology
|
| O: 0.38%
H: 0.38%
C: -3.42%
report genomic market
Arbutus to Participate in Two Upcoming Investor Conferences
Published: 2024-03-08 (Crawled : 12:30) - globenewswire.com
ABUS | $2.97 2.06% 2.68% 3.6M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
Arbutus to Participate in Two Upcoming Investor Conferences - March 8, 2024
Published: 2024-03-08 (Crawled : 14:30) - biospace.com/
ABUS | $2.97 2.06% 2.68% 3.6M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
Published: 2024-02-29 (Crawled : 12:30) - globenewswire.com
ROIV | $10.84 -0.91% -0.83% 3.9M
|
Manufacturing
|
| O: 1.2%
H: 0.34%
C: -3.46%
ABUS | $2.97 2.06% 2.68% 3.6M
|
Health Technology
|
| O: -1.37%
H: 0.0%
C: -2.44%
year update financial results
Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
Published: 2024-02-15 (Crawled : 12:30) - globenewswire.com
ABUS | $2.97 2.06% 2.68% 3.6M
|
Health Technology
|
| O: 0.85%
H: 0.0%
C: -1.36%
report year update financial results
Arbutus Announces 2024 Corporate Objectives and Provides Financial Update
Published: 2024-01-08 (Crawled : 13:00) - globenewswire.com
ABUS | $2.97 2.06% 2.68% 3.6M
|
Health Technology
|
| O: 3.32%
H: 3.21%
C: -1.61%
update financial
Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Collaboration with Arbutus Biopharma in Chronic HBV Patients at AASLD
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
ABUS | $2.97 2.06% 2.68% 3.6M
|
Health Technology
|
| O: 1.67%
H: 0.0%
C: -3.28%
hbv003 biopharma collaboration trial
Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver Meeting®
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
ABUS | $2.97 2.06% 2.68% 3.6M
|
Health Technology
|
| O: 1.67%
H: 0.0%
C: -3.28%
vtp-300 meeting liver biopharma trial
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 45% | 55% |
Top 10 Gainers
KAVL | $6.3 135.96% 57.45% 44M
|
Wholesale Trade
PXMD | $0.74 79.7% 44.16% 4.5M
|
Health Technology
DYNT | $0.3704 -5.27% 43.09% 1.6M
|
Health Technology
LGVN P 3 d | $2.93 73.37% 42.52% 56M
|
HUBC | $1.95 50.0% 32.99% 73M
|
n/a
SPCB | $0.4004 45.07% 31.75% 130M
|
Electronic Technology
ONVO | $1.35 33.65% 24.62% 53M
|
Health Technology
OMQS | $0.7038 35.35% 24.3% 3.5M
|
Professional, Scientific, and T...
SNPO | $10.54 29.48% 22.88% 3.9M
|
EEIQ | $1.16 27.46% 20.86% 6.9K
|
Educational Services
Last 48 Hours Insiders Buying
RMCF | $3.6492 2.51% -7.2% 7.1K
|
Consumer Non-Durables
|
20:10